PATIENT ADVOCACY & HEALTH EQUITY innopiphany
2022-04-12T00:58:52+00:00
PATIENT ADVOCACY AND HEALTH EQUITY
HOW DO YOU ENGAGE PATIENTS TO ENACT CHANGE?
• Pre-clinical, Phase I & II Economic Analysis & Strategy
• Strategic planning
• Target product profile testing
• Portfolio analysis by reimbursement potential
• Payer needs assessment
• Indication Sequencing from a HEOR & Market Access Perspective
• Global reimbursement assessments
Market Access & HEOR Strategy
• Health Economic study design and implementation
• Phase III, PMA & 510K economic analysis
• Prospective Study Design and Statistical Analysis
• Disease Registry Design & Phase IV
• Peer-reviewed publication and value communications
• Value framework global strategy
Proof of Value
• Presentation preparation & sales training targeting payers
• Value-based payment analysis
• Reimbursement dossiers
• Market access tools: Graphical user interfaces & Pro Forma’s
• Publication and symposia
• Public speaking
